379,380,381 Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may act directly on DRG neurons by inhibiting the activation of inflammatory vesicle signaling pathways
Preclinical research has demonstrated cytoprotective properties across multiple organ systems, including the gastrointestinal tract, liver, pancreas, heart, and nervous system
Individuals Seeking Metabolic Health Improvements This combination may be appropriate for people who want to improve their overall metabolic health, especially if they experience difficulty with weight loss, low energy, and hormonal imbalances
Other options include naltrexone/bupropion combination therapy, which targets hypothalamic appetite centers, or behavioral interventions combined with structured nutrition support